(Q36287127)

13 August 2017

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review (English)

1 reference

13 August 2017

1 reference

1 reference

Fekade Bruck Sime

1

0 references

Jason A. Roberts

Jason A Roberts

5

0 references

Jeffrey Lipman

Jeffrey Lipman

4

0 references

Michael S. Roberts

Michael S Roberts

2

0 references

Sandra L Peake

3

Sandra L Peake

1 reference

13 August 2017

28 July 2012

1 reference

13 August 2017

Annals of Intensive Care

1 reference

13 August 2017

2

1 reference

13 August 2017

1

1 reference

13 August 2017

35

1 reference

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Plasma and tissue pharmacokinetics of cefazolin in patients undergoing elective and semielective abdominal aortic aneurysm open repair surgery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Therapeutic drug monitoring of antimicrobials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Simultaneous determination of 12 beta-lactam antibiotics in human plasma by high-performance liquid chromatography with UV detection: application to therapeutic drug monitoring

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Penetration of ertapenem into muscle measured by in vivo microdialysis in mechanically ventilated patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Using PK/PD to optimize antibiotic dosing for critically ill patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Neurotoxic effects associated with antibiotic use: management considerations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Prospective monitoring of cefepime in intensive care unit adult patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Population pharmacokinetics of ceftazidime in intensive care unit patients: influence of glomerular filtration rate, mechanical ventilation, and reason for admission.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Principles of antibacterial dosing in continuous renal replacement therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

A systematic review on clinical benefits of continuous administration of beta-lactam antibiotics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetic issues for antibiotics in the critically ill patient

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Clinical pharmacodynamics of meropenem in patients with lower respiratory tract infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Cefepime neurotoxicity: case report, pharmacokinetic considerations, and literature review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Reversible coma secondary to cefepime neurotoxicity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Integration of population pharmacokinetics, a pharmacodynamic target, and microbiologic surveillance data to generate a rational empiric dosing strategy for cefepime against Pseudomonas aeruginosa

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics of piperacillin-tazobactam in anuric intensive care patients during continuous venovenous hemodialysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Determination of drug residues in water by the combination of liquid chromatography or capillary electrophoresis with electrospray mass spectrometry.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Low plasma cefepime levels in critically ill septic patients: pharmacokinetic modeling indicates improved troughs with revised dosing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Altered pharmacokinetics of ceftazidime in critically ill patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics of cefepime during continuous venovenous hemodiafiltration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics of meropenem in animals, healthy volunteers, and patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics of continuous renal replacement therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Optimal meropenem concentrations to treat multidrug-resistant Pseudomonas aeruginosa septic shock

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Potential subtherapeutic linezolid and meropenem antibiotic concentrations in a patient with severe burns and sepsis

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Empirical models for dosage optimization of four beta-lactams in critically ill septic patients based on therapeutic drug monitoring of amikacin

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Continuous infusion versus intermittent administration of meropenem in critically ill patients

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock

29 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Prescription of antibiotic agents in Swedish intensive care units is empiric and precise

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Intermittent bolus dosing of ceftazidime in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Prospective determination of serum ceftazidime concentrations in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdominal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Piperacillin penetration into tissue of critically ill patients with sepsis--bolus versus continuous administration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Cefepime overdosage with neurotoxicity recovered by high-volume haemofiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Cefepime-induced encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Clearance of ceftazidime during continuous venovenous haemofiltration in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Pharmacokinetics and dosing regimen of meropenem in critically ill patients receiving continuous venovenous hemofiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Neurotoxicity associated with standard doses of piperacillin in an elderly patient with renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Daily serum piperacillin monitoring is advisable in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Analysis of 12 beta-lactam antibiotics in human plasma by HPLC with ultraviolet detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Current status of therapeutic drug monitoring in Australia and New Zealand: a need for improved assay evaluation, best practice guidelines, and professional development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Development of a novel and automated fluorescent immunoassay for the analysis of beta-lactam antibiotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Augmented renal clearance in the Intensive Care Unit: an illustrative case series

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Cefepime versus cefpirome: the importance of creatinine clearance

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Single dose kinetics of piperacillin during continuous arteriovenous hemodialysis in intensive care patients

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3460787

Continuous infusion ceftazidime in intensive care: a randomized controlled trial

22 September 2018

1 reference

https://api.crossref.org/works/10.1186%2F2110-5820-2-35

Can PK/PD be used in everyday clinical practice

21 January 2018

1 reference

12 December 2020

Influence of protein binding and severity of illness on renal elimination of four cephalosporin drugs in intensive-care patients

1 reference

12 December 2020

Effect of altered volume of distribution on aminoglycoside levels in patients in surgical intensive care

1 reference

12 December 2020

Cyclosporin A monitoring in Australia: consensus recommendations

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in patients undergoing continuous veno-venous hemofiltration.

1 reference

12 December 2020

New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease

1 reference

12 December 2020

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

1 reference

12 December 2020

Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration

1 reference

12 December 2020

Determinants of ceftriaxone clearance by continuous venovenous hemofiltration and hemodialysis

1 reference

12 December 2020

Prevention of resistance: a goal for dose selection for antimicrobial agents

1 reference

12 December 2020

Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia

1 reference

12 December 2020

Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients

1 reference

12 December 2020

Population pharmacokinetics and pharmacodynamics of cefpirome in critically ill patients against Gram-negative bacteria

1 reference

12 December 2020

A pharmacodynamic strategy to optimize empirical antibiotic therapy for gram-negative bacteria in a Brazilian Intensive Care Unit

1 reference

12 December 2020

Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Burns Patients—A One-Year Prospective Study

1 reference

12 December 2020

Pharmacokinetics of cefepime in patients with the sepsis syndrome

1 reference

12 December 2020

The pharmacodynamics of beta-lactams

1 reference

12 December 2020

Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing

1 reference

12 December 2020

Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy

1 reference

12 December 2020

Identifiers

DOI

10.1186/2110-5820-2-35

1 reference

PMC publication ID

3460787

Dimensions Publication ID

13 August 2017

0 references

1 reference

PMC publication ID

3460787

13 August 2017

PubMed publication ID

22839761

1 reference

PMC publication ID

3460787